Benchmark Dose Analysis for Neoplastic and Non-neoplastic Lesions
Benchmark Dose (BMD) analysis for all public neoplastic and non-neoplastic lesion incidence data with best fit models.
The data contained herein were collected in 2019 from a source now known to contain omissions. We plan to replace with an up to date dataset in 2023.
DOI: https://doi.org/10.22427/NTP-DATA-022-00002-0005-000-1